Roxane Alupent Production To Be Halted While GMP Concerns Are Addressed

Roxane Labs is temporarily halting production of its asthma product Alupent following receipt of a July 12 FDA warning letter on GMP deficiencies in the manufacturing of liquid drug products at its Columbus, Ohio facility.